Keywords:
Osteoporosis, Calcifications / Calculi, Instrumentation, CT, Absorptiometry / Bone densitometry, Musculoskeletal bone, Cardiovascular system
Authors:
A. Kokov, V. L. Masenko, S. E. Semenov, O. Barbarash; Kemerovo/RU
References
1.
Tintut Y,
Parhami F,
Tsingotjidou A et al.
8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem.
2002;277:14221-14226.
2. Doherty TM,
Fitzpatrick LA,
Inoue D et al.
Molecular,
Endocrine,
and Genetic Mechanisms of Arterial Calcification. Endocr Rev.
2004;5: 629-672.
3. Broussard D.L.,
Magnus J.H.
Coronary heart disease risk and bone mineral density among U.S.
women and men. J Women’s Health.
2008;17:479-90.
4. Schulz E,
Arfai K,
Liu X et al.
Aortic calcification and the risk of osteoporosis and fractures.
J Clin Endocrinol Metab.
2004;89:4246-53.
5. Kokov AN,
Maliuta EB,
Masenko VL,
et al.
Evaluation of coronary artery lesion in men with osteopenic syndrome and coronary artery disease.
Ter Arkh.
2014;86:65–70.
Russian.